Undervalued Stocks to Consider: Pfizer, Confluent, and Kinder Morgan
-
Pfizer's stock has lagged despite its role in COVID vaccines and treatments. It has strong existing drugs and pipeline, low valuations, and high dividend yield.
-
Confluent's stock fell on recent volatility, but its data streaming growth story remains intact. Revenue and cloud growth still strong, margins improving, cash flows strengthening.
-
Kinder Morgan operates pipelines essential for transporting oil and gas. Stable decades-long outlook, but stock hasn't moved in 5+ years despite solid cash flow generation.
-
Pfizer and Kinder Morgan shares look undervalued based on cash flows and dividends. Confluent looks well positioned as data streaming expands.
-
Now could be a good time to take a closer look at these stocks while they remain left behind by the recent bull market.